2022-RA-1470-ESGO Is neoadjuvant chemotherapy effective as prehabilitation program in advanced epithelial ovarian cancer? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

2022-RA-1470-ESGO Is neoadjuvant chemotherapy effective as prehabilitation program in advanced epithelial ovarian cancer?

Free

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

	Abstract	Full	Pdf
Oct 2022	6	0	0
Nov 2022	30	0	2
Dec 2022	42	0	10
Jan 2023	19	0	3
Feb 2023	8	0	1
Mar 2023	7	0	0
Apr 2023	14	0	1
May 2023	6	0	0
Jun 2023	4	0	1
Jul 2023	8	0	4
Aug 2023	2	0	1
Sep 2023	0	0	3
Oct 2023	8	0	5
Nov 2023	8	0	1
Dec 2023	18	0	4
Jan 2024	8	0	1
Feb 2024	6	0	1
Mar 2024	8	0	4
Apr 2024	12	0	5
Total	214	0	47